quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:09·819d
SECFiling
Mirati Therapeutics Inc. logo

SEC Form EFFECT filed by Mirati Therapeutics Inc.

MRTX· Mirati Therapeutics Inc.
Health Care
Original source

Companies

  • MRTX
    Mirati Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Aug 10UpdateCitigroup$48.00
  • Aug 9UpdateB. Riley Securities$45.00
  • Aug 9UpdatePiper Sandler$45.00
  • Jul 27UpdateScotiabank-
  • May 25UpdateOppenheimer-
  • Dec 14UpdateNeedham-

Related

  • 13D/G799d
    SEC Form SC 13G filed by Mirati Therapeutics Inc.
  • 13D/G799d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
  • 13D/G800d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G filed by Mirati Therapeutics Inc.
  • 13D/G805d
    SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022